Open AccessMalignant epithelioid hemangioendothelioma progressing after chemotherapy and Interferon treatment: A case presentation and a brief review of the literature
Author(s) -
Lütfiye Demir,
Alper Can,
Rukiye Mine Oztop,
Ahmet Dirican,
Vedat Bayoğlu,
Murat Akyol,
Yüksel Küçükzeybek,
Çiğdem Erten,
İşıl Somali,
Mustafa Oktay Tarhan
Publication year - 2013
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.110386
Subject(s) - medicine , epithelioid hemangioendothelioma , hemangioendothelioma , chemotherapy , soft tissue , pathology , abdominal distension , surgery , immunohistochemistry
Epithelioid hemangioendothelioma is a rare, low-grade malignant vascular tumour. It is frequently seen in the liver, but can occur in the lungs, bones, and other soft tissues. Although survival time might be reasonable in cases that can undergo liver transplantation, there is no consensus on the treatment of metastatic patients. We report a 24-year-old female patient with rapidly progressing malignant epithelioid hemangioendothelioma that presented with acute abdominal distension. The patient was refractory to anthracycline and Interferon treatment and died 6.5 months after the diagnosis.